United States · FDA National Drug Code directory
Fycompa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69616-272_98f5e818-1e3f-43a8-9a56-9c44e639f431
- Product NDC
- 69616-272
- Form
- TABLET
- Composition / generic term
- perampanel
- Labeler
- Catalyst Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240102
- Source listing expiry
- 20261231
Source-listed ingredients
- PERAMPANEL — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET in 1 PACKAGE (69616-272-14) · 69616-272-14
- 30 TABLET in 1 BOTTLE (69616-272-30) · 69616-272-30
- 90 TABLET in 1 BOTTLE (69616-272-90) · 69616-272-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →